The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dvoryankova E.V.

Center for Theoretical Problems of Physicochemical Pharmacology of Institution of Russian Academy of Sciences

Lipid transport systems for transdermal drug delivery (using methylprednisolone aceponate as a model)

Authors:

Dvoryankova E.V.

More about the authors

Read: 2852 times


To cite this article:

Dvoryankova EV. Lipid transport systems for transdermal drug delivery (using methylprednisolone aceponate as a model). Russian Journal of Clinical Dermatology and Venereology. 2022;21(1):99‑105. (In Russ.)
https://doi.org/10.17116/klinderma20222101199

References:

  1. Alexander A, Dwivedi S, Ajazuddin TK, Giri S, Saraf S, Tripathi DK. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release. 2012;164(1):26-40. 
  2. Nastiti C, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics. 2017;9(4):37.  https://doi.org/10.3390/pharmaceutics9040037
  3. Zhai Y, Zhai G. Advances in lipid-based colloid systems as drug carrier for topic delivery. J Contro Release. 2014;193:90-99. 
  4. Hadgraft J. Skin, the final frontier. Int J Pharm. 2001;224:1-18.  https://doi.org/10.1016/s0378-5173(01)00731-1
  5. Jadoul A, Doucet J, Durand D, Preat V. Modifications induced on stratum corneum structure after in vitro iontophoresis: ATR-FTIR and X-ray scattering studies. J Control Release. 1996;42:165-173.  https://doi.org/10.1016/0168-3659(96)01452-6
  6. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. Microemulsions for topical delivery of estradiol. Int J Pharm. 2003;254:99-107.  https://doi.org/10.1016/s0378-5173(02)00632-4
  7. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004; 56:603-618.  https://doi.org/10.1016/j.addr.2003.10.025
  8. Thacharodi D, Panduranga Rao K. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm. 1994;111(3):235-240. 
  9. Chandrasekaran SK, Bayne W, Shaw JE. Pharmacokinetics of drug permeation through human skin. J Pharm Sci. 1978;67:1370-1374.
  10. Pardeikea J, Schwabea K, Müller HR. Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect. Int J Pharm. 2010;396:166-173. 
  11. Sanna V, Gavini E. Production of lipospheres for bioactive compound delivery. AAPS Pharm Sci Tech. 2003;5:1-7. 
  12. Yang Y, Huafeng Z, Guanlan L, Yan Li, Zemin Y. The advantages of a novel CoQ10 delivery system in skin photo-protection. Int J Pharm. 2010;392:57-63. 
  13. Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 2007;345:163-171. 
  14. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238-252. 
  15. Constantinidis PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995; 12:1561-1572.
  16. Meilander NJ, Yu X, Ziats NP, Bellam-Konda RV. Lipid-based microtubular drug delivery vehicles. J Control Rel. 2001;71:141-152. 
  17. Semalty A, Semalty M, Rawat BS, Singh D, Rawat MSM. Pharmacosomes: the lipid-based new drug delivery system. Exp. 747. Opin Drug Del. 2009; 6:599-612. 
  18. Garcia-fuentes M, Torres D, Alonso MJ. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm. 2005; 296:122-132. 
  19. Vyas SP, Rawat M, Rawat A, Mahor S, Gupta PN. Pegylated Protein Encapsulated Multivesicular Liposomes: A Novel Approach for Sustained Release of Interferon-a. Drug Dev Ind Pharm. 2006;32:699-707. 
  20. Shengping Q, Charles FC, Katherine WF. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phy Med Biol. 2009;54:R27. 
  21. Jin-Woong K, Alberto FN, Nily Dan, Andrew SU, Manuel M, David AW. Colloidal Assembly Route for Responsive Colloidosomes with Tunable Permeability. Nano Lett. 2007;7:2876-2880.
  22. Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413:194-201. 
  23. Shah JC, Sadhale, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Del Rev. 2001;47:229-250. 
  24. Rawat M, Singh D, Saraf S. Archaeosomes — Archaebacteria Derived Novel Liposomes. Indian Drugs. 2007;44:497-503. 
  25. Sjöblom J, Lindberg R, Friberg SE. Microemulsions — phase equilibria characterization, structures, applications and chemical reactions. Adv Colloid Interface Sci. 1996;65:125-287. 
  26. Reithmeier H, Hermann J, Gopferich A. Lipid microparticles as a parenteral controlled release device for peptides. J Control Rel. 2001;73:339-350. 
  27. Shinoda K, Lindman B. Organized surfactant systems: microemulsions. Langmuir. 1987;3(2):135-149. 
  28. Neubert RHH, Sommer E, Schölzel M, Tuchscherer B, Mrestani Y, Wohlrab J. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK. Eur J Pharm Biopharm. 2018;124:28-33. 
  29. Alexander A, Ajazuddin RJ, Patel S, Saraf Saraf S. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. J Control Release. 2016;241:110-124. 
  30. Agrawal M, Saraf Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, et al. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region& Expert Opin Drug Deliv. 2018;15(6):589-617. 
  31. Chiappisi L, Noirez L, Gradzielski M. A journey through the phase diagram of a pharmaceutically relevant microemulsion system. J Colloid Interface Sci. 2016;473:52-59. 
  32. Lee J, Lee Y, Kim J, Yoon M, Choi YW. Formulation of microemulsion systems for transdermal delivery of aceclofenac. Arch Pharm Res. 2005;28(9): 1097-1102.
  33. Devaraj NK, Aneesa AR, Abdul Hadi AM, Shaira N. Topical corticosteroids in clinical practice. Med J Malaysia. 2019;74(2):187-189. PMID: 31079135.
  34. Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders — a clinical update. Int J Clin Pract. 2006;60:85-92. 
  35. Tauber U. Pharmacokinetics and bioactivation of MPA. J Eur Acad Dermatol Venereol. 1994;3(1):23-31. 
  36. Mirshahpanah P, Docke W-D, Merbold U, et al. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. Exp Dermatol. 2007;16:753-761. 
  37. Bieber T, Vick K, Fo€lster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62:184-189. 
  38. Luger TA. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol. 2011;25:251-258. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.